May 2, 2025 07:00 AM EDTUpdated 09:02 AM

Former Tome CEO joins Flagship startup; NGM Bio chief steps down as restructuring takes effect

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Ryan Cross

Senior Science Correspondent

Flagship Pioneering has recruited Rahul Kakkar to lead its genetics-based drug discovery startup Quotient Therapeutics. Kakkar was most recently CEO of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Former Tome CEO joins Flagship startup; NGM Bio chief steps down as restructuring takes effect

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Exclusive: Vertex drops AAV gene therapy research, tRNA therapy partnership

Drugmakers exploit cancer’s ‘lethalities’ to make next class of targeted therapies, with first results for ...

Exclusive: After FDA firings, drug reviewers are asked to volunteer for administrative work

Feng Zhang’s protein nanoparticle startup Aera Therapeutics turns to lipid nanoparticles to jumpstart its pipeline

The inside story of how SalioGen, a startup trying to wrangle ‘jumping genes’ to make medicines, fell apart

Revolutionizing obesity treatment: Could mitochondria hold the key to unlocking fat-specific weight loss?

For­mer Tome CEO joins Flag­ship start­up; NGM Bio chief steps down as re­struc­tur­ing takes ef­fect

Copy Chief

Editor

Senior Science Correspondent

Sign up to read this article for free.

Former Tome CEO joins Flagship startup; NGM Bio chief steps down as restructuring takes effect